Bioequivalence of Ethylenediamine Dihydrochloride Study
NCT01798589
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Contact Dermatitis
Interventions
DRUG:
Ethylenediamine dihydrochloride allergen patch
Sponsor
Allerderm